Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury

Circulation

Volumn 110, Issue 16, 2004, Pages 2430-2435

  Hutter, Randolph ^a   Carrick, Francine E ^a   Valdiviezo, Carolina ^a   Wolinsky, Claire ^a   Rudge, John S ^b   Wiegand, Stanley J ^b   Fuster, Valentin ^a   Badimon, Juan J ^a   Sauter, Bernhard V ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Regeneron Pharmaceutical Inc   (United States)

Author keywords

Angiogenesis; Endothelium; Gene therapy; Stenosis

Indexed keywords

CHIMERIC PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL REGENERATION; CHIMERA; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REENDOTHELIALIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY; ANIMALS; CELL DIVISION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; HYPERPLASIA; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SINGLE-BLIND METHOD; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 6444220780     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000145120.37891.8A     Document Type: Article

References (21)

1. Luscher TF, Tanner FC, Tschudi MR, et al. Endothelial dysfunction in coronary artery disease. Annu Rev Med. 1993;44:395-418.
2. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
3. Bjornsson TD, Dryjski M, Tluczek J, et al. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991;88:8651-8655.
4. Ross R. Rous-Whipple Award Lecture: atherosclerosis: a defense mechanism gone awry. Am J Pathol. 1993;143:987-1002.
5. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103: 1231-1236.
6. Asahara T, Chen D, Tsurumi Y, et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation. 1996;94:3291-3302.
7. Vane JR, Anggard EE, Bolting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
8. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
9. Hutter R, Sauter BV, Reis ED, et al. Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation. 2003;107:1658-1663.
10. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-858.
11. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-1312.
12. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470-1478.
13. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
14. Holash J, Davis S, Papadopoulos N, et al. VEGF-trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A. 2002;99: 11393-11398.
15. Takeshita S, Rossow ST, Kearney M, et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol. 1995;147:1649-1660.
16. Callow AD, Choi ET, Trachtenberg JD, et al. Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty. Growth Factors. 1994;10:223-228.
17. Gennaro G, Menard C, Michaud SE, et al. Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. Circulation. 2003;107:230-233.
18. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
19. Roque M, Fallon JT, Badimon JJ, et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335-342.
20. Hayashi K, Nakamura S, Morishita R, et al. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther. 2000;7:1664-1671.
21. Lindner V, Reidy MA. Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF. Arterioscler Thromb Vasc Biol. 1996;16:1399-1405.